Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Phillys Leading AI Biotechs
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings…
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
WARREN, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio…
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
March 17, 2025 08:00 ET | Source: Enlivex Therapeutics Ltd Nes-Ziona, Israel,…
Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
– First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) – –…
Tevogen Bios First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
600% higher market cap per team member when compared to industry average.…
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH,…
ALKs house dust mite tablet (ACARIZAX) now recommended by NICE for use in the UK health system
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the…
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
This expansion is in addition to the previously announced Microsoft for Startups…
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
This expansion is in addition to the previously announced Microsoft for Startups…